← FDA Drug Approvals (Drugs@FDA)
EPOPROSTENOL SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2025-12-29
Drug application
- FDA Application #
ANDA219237- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EPOPROSTENOL SODIUM
- Generic name
- EPOPROSTENOL
- Active ingredients
- EPOPROSTENOL SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- GLAND
- Manufacturer
- Gland Pharma Limited
- First approval
- 2025-12-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown